-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IE478NbWi6RxpvjI8YmPT3+N93ATdwee7trH4qy/iYIITQY13sVhiDUw6HfLAq84 tcVGES0BuTpAu0D0Tl5UNA== 0001144204-09-010588.txt : 20090224 0001144204-09-010588.hdr.sgml : 20090224 20090224114457 ACCESSION NUMBER: 0001144204-09-010588 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20090224 DATE AS OF CHANGE: 20090224 EFFECTIVENESS DATE: 20090224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LCA VISION INC CENTRAL INDEX KEY: 0001003130 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 112882328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-27610 FILM NUMBER: 09629973 BUSINESS ADDRESS: STREET 1: 7840 MONTGOMERY RD CITY: CINCINNATI STATE: OH ZIP: 45236 BUSINESS PHONE: 5137929292 MAIL ADDRESS: STREET 1: 7840 MONTGOMERY ROAD CITY: CINCINNATI STATE: OH ZIP: 45236 DEFA14A 1 v141177_defa14a.htm Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14-A
(Rule 14A-101)

PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES AND EXCHANGE ACT OF 1934

Filed by the Registrant þ
Filed by a Party other than the Registrant o

Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
þ Definitive Additional Materials
o Soliciting Materials Pursuant to Section 240.14a.12


LCA-Vision Inc.
(Name of Registrant as Specified in its Charter)

 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

þ No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11

1)      
Title of each class of securities to which the transaction applies:
 
__________________________________________________________________
 
2)      
Aggregate number of securities to which transaction applies:
 
__________________________________________________________________
 
3)      
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
__________________________________________________________________

4)      
Proposed maximum aggregate value of transaction:
 
__________________________________________________________________

5)      
Total fee paid:

__________________________________________________________________
 


Fee paid previously with preliminary materials
 
o
Check box if any part of the fee is offset by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was previously paid.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
1.     
Amount Previously Paid:
 
__________________________________________________________________

2.      
Form, Schedule or Registration No.:
 
__________________________________________________________________

3.      
Filing Party:
 
__________________________________________________________________

4.      
Date Filed:
 
__________________________________________________________________
 
 


 
On February 24, 2009, LCA-Vision Inc. sent the following letter to RiskMetrics Group Inc.
 
 

7840 Montgomery Road
Cincinnati, Ohio 45236

February 24, 2009

RiskMetrics Group Inc.
2099 Gaither Road
Rockville, MD 20850-4045

Re: 
LCA-Vision Responds to Joffe Group Inaccuracies

We uncovered numerous inaccuracies, errors and differences in calculations in the Joffe Group presentation dated February 20, 2009 filed with the Securities and Exchange Commission.  We appreciate the opportunity to alert RiskMetrics to LCA-Vision’s support for and calculations behind just a few of these items.
 

 
·
Calculation of 2008 Adjusted EBITDA by the Joffe Group of $(7.1 million) (slide 6).
LCA-Vision calculated adjusted EBITDA for 2008 was $(1.3 million).  This number was calculated as follows:
 
   
(in thousands)
 
Pretax loss
  $ (9,258 )
Minus deferred revenue
  $ (16,847 )
Plus depreciation
  $ 17,972  
Plus investment loss
  $ 1,524  
Plus restructuring charges
  $ 2,923  
Plus impairment charge
  $ 553  
Plus stock-based compensation expense
  $ 1,878  
Adjusted EBITDA
  $ (1,255 )

Regardless, cost savings implemented in 2008 will result in 2009 being adjusted EBITDA positive at the 2008 procedure volume level of 115,000.

·
Error in Market Share Data (slide 7):
Correct amounts are:
 
 
Joffe Group Claims
Actual (from MarketScope)
Q107
14.1%
14.4%
Q207
12.7%
12.9%
Q307
14.0%
14.2%
Q407
14.5%
14.8%
     
Q108
11.9%
12.2%
Q208
10.4%
10.5%
Q308
10.3%
10.5%
Q408
 
11.9%

Due to the direct marketing approach and “catch and release” model, LCA-Vision has had a competitive advantage in times of strong consumer confidence, yet has been considerably less effective in times of a deteriorating macroeconomic environment.  Essentially, LCA-Vision has a “high-beta” business model, meaning industry trends – whether positive or negative – are exaggerated in LCA-Vision’s operating performance.  Note that in last recession, under the leadership of Stephen Joffe, market share shrank from 6.2% in the first quarter of 2001 to 3.8% in the fourth quarter of 2001.

LCA-Vision management has undertaken numerous initiatives to improve its business.  Management stabilized market share in third quarter of 2008 and improved it in fourth quarter of 2008.

·
Claim of “no response” to surgeon letter (slide 15):
Concerns raised by the surgeons were taken seriously and management and the Board of Directors have responded in several ways:
 
 
·
Instituted meetings and conference calls with surgeons across the country, providing a forum for exchanging ideas, updating progress on key initiatives and strengthening surgeon participation in driving the business forward.  Feedback from these discussions has been supportive.
 
·
Expanded the role of the Medical Advisory Board with surgeon members serving as advisors in areas of operations, human resources, finance, marketing and business model expansion.
 
·
Solicited surgeon input in development of new staffing models for vision centers in response to the drop in patient volumes, including holding market-by-market phone discussions with each surgeon, Regional Director and area Vice President.
 
·
Established a process for reviewing with one or more members of the Medical Advisory Board as appropriate potential termination of relationship with select surgeons before reaching a final decision.
 
·
Integrated surgeons into the vision center business model, increasing medical perspectives and support regarding clinical care, patient management and marketing initiatives. Expanded the membership and responsibilities of the Medical Advisory Board to include clinical, operational, human resources, marketing and customer service input; conducted monthly conference calls.
 
·
Provided 22 surgeons the opportunity to perform laser vision correction surgical procedures in nearby LasikPlus vision centers to enhance surgeon income, while providing positive patient experiences and continuity of care with the vision center staff.
 

 
·
Incorrect assertion that each 1% market share equals approximately $10 million of free cash flow (slide 19):
The $10 million amount is pretax number and assumes the total annual industry volume is about 1.0 million eyes.  MarketScope projects 740,000 procedures in 2009.  This $10 million amount does not account for taxes or the changes to the size of the market.  Assuming 740,000 procedures a 1% market share gain would result in approximately $4.4 million of free cash flow, not $10 million.

·
Assumption that LCA Vision full year 2009 procedure volume will exceed a 35% year-over-year decline (slide 29):
We expect first quarter of 2009 procedure volume to be down about 35% from the first quarter of 2008, and 51% from the first quarter of 2007.  The industry and LCA-Vision declined on a sliding scale during 2008.  Our performance in 2008 compared with 2007 was:

Q108 down 25%
Q208 down 38%
Q308 down 52%
Q408 down 51%

LCA-Vision essentially reached its plateau year-over-year percentage decline in June at about 51% below 2007 and has stayed at that level despite continued erosion in consumer confidence.  Even with no improvement from the current position, the 2009 decline would be less than 20%.

·
Incorrect 2009 Projected Cash Flow of ($50 million) (slide 29):
If procedure volume remains at 51% below 2007 for all of 2009, LCA-Vision will perform approximately 94,000 procedures and use about $10 million -$15 million of cash, rather than the $50 million asserted by the Joffe Group.  The Joffe Group failed to account for volume seasonality and the decline that occurred during 2008.

·
Overestimation of costs for Lifetime Vision Model (slide 34):
LCA-Vision has stated publicly that capital expenditures related to implementing the Lifetime Vision program will be minimal as we will contract with ambulatory surgery centers to use their equipment and surgery suites.  We have factored customary ambulatory surgery center fees into our preliminary calculations.

·
Error in $100 million of cash "lost" statement (slide 42):
LCA-Vision used $97 million of cash to repurchase stock in 2006 and 2007.  The stock buy-backs were accretive to earnings per share at the time and had the full support of Joffe Group members Alan Buckey, then Chief Financial Officer, and Craig Joffe during his tenure as interim CEO.


Thank you in advance for your consideration of the above comments.
 


 
GRAPHIC 2 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86 M&#$C)1TH.C,]/#DS.#=`2%Q.0$17137!D>%QE9V/_ MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`!)`*@#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BDHH`6B MDHH`6BDHH`6BDHH`6BDK*MW8^*;U"S%!:Q$+G@'<]`&M125DZU/*\]GIEO*\ M$EXS9E3[R(HRV/<\#\:`->BLK^P;1-C0/<12JP/FK.Y9L=CDG(-:E`"T5% M""Q/4CU%;U&<=:`$'(SC'M6=K%G-/Y%W9A#>6CEXPYP'!&&4_4?KBK$NH6\> M1OW'T7FJSZE(W^K0+]>:I0;%<@CU?4)I$A31+F.0D!VF91&@[G()S^5;58YN M)WZR-^'%)ND/61S^-5R!67=<.IQA%YQ^)Q^M4;_P^MF(; M_3C=3W=K('6.2=GWKT91N/&15O?*.DCCZ-2K=W"'[^X>A&:7(PN:ZG*@X(SV M-+6?%JB])D*^Z\UU2:_6\M[P*+JSG:*3:,!AGY2/J/Y5L5R]YC1_&5O=\K;:FGDR^@ MD'W3^/`_.@"]KFJ3VM]IMC9;/M%W-AMPSMC'WCC_`#T-;5NGH`Q9M4N$\7V^F#9]GDMC*W'S;LD=?PK:KF+K_DHUG_ M`->+?^A-73T`8.JZG?R:NFD:0L2W'E^=+--RJ)G'`[G-3Z4^M1W+P:HD$T6W M<_2H==TCS;F/5+2\-E>0KM\S&Y77^ZP[UG6VMZC>W\6EWD*6 MTDRDI-&3LE`ZX[BFE<1T%WJD-N=B_O']%Z#ZFN<_M6_U#Q$]@2ODBW\T*HQ@ MY`Y-:T]O8:3!YUXQE9CM1`N2[=@JCJ:YA[*Z\0>+I(+D2:8KV8+1H06:/<.# MV&>OX5=XQV%J]RSJ7B#3M,+]9!S]H3Z>4O\`A5^Q\.=/5/D;_"N3KI_!&FVNJ75Y M;WD*R1^3D'H5.1R#VZFINQG7Z3KMAK&5MG*R@9,4@PWX>M+KES)8:5<740!> M(`C(X/S"N.\0>&KGP^Z7MG,[P!N''#1GMG_&NAU2>2Y\"M/,VZ22W1F;'4DC M-6I,DM:;J$6J6AGB5E*G:Z-U0U7US4+C2]/:ZM6"RJR@9&>IJ[=:3<+%;:QI M./M0MT$UN1\MPN!P??WK'\1W5KJ?A22\M28V615E@;[T39Z4U.ZLPL==8ZJL M@5+C"N?XNQ_PK3'-P4L2<$@9]**D$E=!%EZBBBLBA*Q/&%C) M?:!-Y!Q-`1.GU7G^6:VZ",C%`&5X9TXZ7H5K;N],6)0Y<\L>YH`Y3 M4;B\T_6S=ZG;SRZ=(JE/*RXA(_O#^HJ6SDEU_P`166HPVLT%C8H^V29=IE+# M'`]*ZK%%-NX%&"P(U"2]G??*RA$7^&-1Z9[GN>^*RHH91\099C&_E&P"A]IV MD[AQFNCHI`%<7X]\.S:B8[^S`::-=C18Y<9R"#ZUVE,EC$J%&Z&@#Q)-&U-Y M?*6PN=_IY9%>@^#]#DT6UE>Y8&>?:64?P`9XSWZUM2(\+8;IV/8T!_>M%'L3 M<6YC2X@>&0`HZE2#[U@ZQ8O!X2ELH0\S1Q*B[5Y;!'85MEJM6EN<^9(,?W13 M>B`FL%*V%LI!!$2@@]N!7'>-]`N-MQJ-@"RRJOVF%1UPAJ$V<)_AQ]#5B @BG>P$26\49RJ#/K4F*6BD`E%+10`E%+10`4444`?_]D_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----